MedTrace Logo

Normal Variants and Pitfalls of 18F_FDG PET/CT in Pediatric Oncology

NCT06612567 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-09-25

No results posted yet for this study

Summary

Detection Normal variants and pitfalls of 18\_F \_FDG PET/CT imaging in pediatic oncology.

Conditions

  • Pitfalls of PET Scan on Pediattic

Interventions

DIAGNOSTIC_TEST

PET/CT

is an imaging test that can help reveal the metabolic or biochemical function of your tissues and organs. The PET scan uses a radioactive drug called a tracer to show both typical and atypical metabolic activity. A PET scan can often detect the atypical metabolism of the tracer in diseases before the disease shows up on other imaging tests, such as computerized tomography (CT) and magnetic resonance imaging (MRI).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2026-07-31
Completion
2026-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06612567 on ClinicalTrials.gov